| Unique ID issued by UMIN | UMIN000059862 |
|---|---|
| Receipt number | R000068454 |
| Scientific Title | The long-term natural history study of Duchenne muscular dystrophy |
| Date of disclosure of the study information | 2025/11/23 |
| Last modified on | 2025/11/23 17:09:30 |
The long-term natural history study of Duchenne muscular dystrophy
LNH-DMD
The long-term natural history study of Duchenne muscular dystrophy
LNH-DMD
| Japan |
Duchenne muscular dystrophy
| Neurology | Pediatrics | Rehabilitation medicine |
Others
NO
To investigate the long-term natural history data of motor function in ambulatory patients with Duchenne muscular dystrophy (DMD) receiving standard care in Japan until they become non-ambulatory.
Others
This study is aimed to select avairable outcome measure of motor function test that reflect the longitudinal progression of DMD.
Others
Others
Not applicable
Motor function test
Subject demographics
Observational
| 4 | years-old | <= |
| Not applicable |
Male
1) Patients with a dystrophin abnormality proven by dystrophin gene testing or muscle pathology and a definitive diagnosis of DMD
2) Sex: male
3) Aged 4 or older (at the time of informed consent)
4) Able to rise from the floor and walk independently at baseline
5) Patients receiving oral glucocorticosteroids for at least 6 months before baseline without change in dosage or dosing regimen within 3 months and having stable symptoms
6) If participating in another clinical study, at least 6 months has passed since starting this study at baseline
7) Patients who participated in the previous study (UMIN000030562) and are able to walk at baseline in this study
1) Patients with clinically apparent symptoms of cardiac failure and/or respiratory failure as determined by the investigators
2) Patients continuously using a ventilator (use of non-invasive positive-pressure ventilation [NPPV] during sleep is allowed)
3) Patients with behavior abnormalities including intellectual disability, autistic tendency, and attention deficit hyperactivity disorder that, in the opinion of the investigators, could prevent to conduct the assessment of motor function
4) Other patients as determined by the investigators to be ineligible to participate in this study
5) Patients participating in another clinical trial at baseline (This restriction does not apply to patients who have continued participation from the previous study (UMIN000030562).)
80
| 1st name | Eri |
| Middle name | |
| Last name | Takeshita |
National Center Hospital, National Center of Neurology and Psychiatry (NCNP)
Department of Child Neurology
187-8551
4-1-1 Ogawahigashi-cho, Kodaira, Tokyo 187-8551, Japan
042-341-2711
erit@ncnp.go.jp
| 1st name | Mikiko |
| Middle name | |
| Last name | Shigemori |
CareCure NMD
Secretariat Office
1878551
4-1-1 Ogawahigashi-cho, Kodaira, Tokyo 187-8551, Japan
042-341-2711
shigemori@ncnp.go.jp
National Center of Neurology and Psychiatry (NCNP)
Eri Takeshita
National Center of Neurology and Psychiatry (NCNP)
Self funding
National Center of Neurology and Psychiatry (NCNP)
4-1-1 Ogawahigashi-cho, Kodaira, Tokyo 187-8551, Japan
042-341-2711
ml_rinrijimu@ncnp.go.jp
NO
国立病院機構医王病院(石川県)
国立病院機構長良医療センター(岐阜県)
東京女子医科大学病院(東京都)
国立病院機構まつもと医療センター(長野県)
国立精神・神経医療研究センター病院(東京都)
| 2025 | Year | 11 | Month | 23 | Day |
Unpublished
Enrolling by invitation
| 2024 | Year | 09 | Month | 20 | Day |
| 2024 | Year | 10 | Month | 04 | Day |
| 2025 | Year | 05 | Month | 01 | Day |
| 2029 | Year | 08 | Month | 31 | Day |
Prospective observational study now underway.
| 2025 | Year | 11 | Month | 23 | Day |
| 2025 | Year | 11 | Month | 23 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000068454